Since the FDA's decision to defer sweeping CBD regulations to Congress, CBD companies, consumers and trade associations alike are left with many more questions regarding the future of CBD than answers. That's why we are tapping into the expertise of Josh Long, Associate Editorial Director of Natural Products Insider, and Dr. Dan Fabricant, President and CEO of the Natural Products Association to discuss the decision. Together they offer excellent insight into how you can turn this challenge into an opportunity for your CBD business.